Medical Marijuana NY-Based Biotech Company Enters Clinical Trials

Controlled-release hemp oil CBD chewing gum and matching placebo gums will be tested for the clinical studies

NEW YORK:  AXIM Biotechnologies, Inc., a world leader in cannabinoid research and development, has entered clinical trials on treating irritable bowel syndrome (IBS) with the Company’s CanChew Plus cannabidiol (CBD) gum at Wageningen University in the Netherlands. Human Clinical Trials Detail Include: Controlled-release hemp oil CBD chewing gum and matching placebo gums will be tested for the Read the full article…